These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3291264)

  • 21. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3.
    Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D
    Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852
    [No Abstract]   [Full Text] [Related]  

  • 22. Optimization of cyclosporine monotherapy--long-term graft function.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
    [No Abstract]   [Full Text] [Related]  

  • 23. Sequential conventional and cyclosporine therapy in cadaver renal transplantation--a prospective randomized trial.
    Grundmann R; Wienand P; Hesse U
    Transplant Proc; 1987 Oct; 19(5):4033-4. PubMed ID: 3313993
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative efficacy of prophylactic monoclonal (OKT3) and polyclonal antibodies (ATG) in immunologic high-risk renal transplant recipients.
    Fukuuchi F; Lefrançois N; Chapuis F; Gebuhrer L; Bosshard S; Dubernard JM; Touraine JL
    Transplant Proc; 1996 Oct; 28(5):2808-9. PubMed ID: 8908070
    [No Abstract]   [Full Text] [Related]  

  • 25. Heterotopic versus orthotopic heart transplantation.
    Barnard CN; Cooper DK
    Transplant Proc; 1984 Jun; 16(3):886-92. PubMed ID: 6375048
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
    J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are there indications for heterotopic heart transplantation today?
    Becerra E; Cooper DK; Novitzky D; Reichart B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2512-3. PubMed ID: 3274551
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of immunosuppression on pancreatic graft survival and function.
    La Rocca E; Dubernard JM; Camozzi L; LeFrancois N; Faure JL; Sanseverino R; Melandri M; Finaz J; Martin X; Gelet A
    Transplant Proc; 1987 Oct; 19(5):3950-2. PubMed ID: 3313972
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of prostaglandin E1 therapy on cyclosporine A and creatinine levels after orthotopic heart transplantation.
    Iberer F; Vujicic R; Rödl S; Wasler A; Sabin K; Koshsorur A; Allmayer T; Auer T; Petutschnigg B; Tscheliessnigg KH
    Transplant Proc; 1994 Dec; 26(6):3246-8. PubMed ID: 7998131
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term effects of cyclosporine in cardiac transplantation.
    Miller LW; Pennington DG; McBride LR
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):15-20. PubMed ID: 2349734
    [No Abstract]   [Full Text] [Related]  

  • 31. Triple and quadruple therapy after renal transplantation in patients from developing countries.
    Slapak M; Shell T; Digard N; Gosling DC; Qerchi della Rovera G; Crockett RC; Ahmed K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1922-5. PubMed ID: 3547896
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytomegalovirus infection in pediatric heart transplantation.
    Fukushima N; Gundry SR; Razzouk AJ; Bailey LL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1423-5. PubMed ID: 8382868
    [No Abstract]   [Full Text] [Related]  

  • 33. Four years' experience with cyclosporine A in pediatric kidney transplantation.
    Hoyer PF; Offner G; Oemar BS; Brodehl J; Ringe B; Pichlmayr R
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):274-9. PubMed ID: 3291256
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of steroids in combination with other pharmacologic immunosuppressive agents.
    Salaman JR
    J Heart Transplant; 1986; 5(4):304-6. PubMed ID: 3305822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [After care of kidney transplant patients].
    Castro LA; Eigler J; Land W
    Internist (Berl); 1983 Sep; 24(9):510-6. PubMed ID: 6313541
    [No Abstract]   [Full Text] [Related]  

  • 36. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
    Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
    [No Abstract]   [Full Text] [Related]  

  • 37. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
    Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
    Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
    [No Abstract]   [Full Text] [Related]  

  • 38. Early steroid withdrawal after renal transplantation.
    Colaneri J
    Nephrol Nurs J; 2006; 33(1):89-90. PubMed ID: 16538935
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduced infection in cardiac transplant recipients.
    Dresdale AR; Drusin RE; Lamb J; Smith CR; Reemtsma K; Rose EA
    Circulation; 1985 Sep; 72(3 Pt 2):II237-40. PubMed ID: 3896557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppression with or without ATG in heart transplantation.
    Berglin E; Berggren H; Nilsson F; Svensson S
    Transplant Proc; 1994 Jun; 26(3):1811. PubMed ID: 8030148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.